Drug interaction study of HSK31858 and itraconazole
This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Healthy adults aged 18 to 45
- Body weight at least 110 lb (50 kg) for men, 99 lb (45 kg) for women, with a BMI between 19 and 26
- No known allergies to HSK31858, itraconazole, or similar drugs, and no severe allergies
- Willing to avoid caffeine, grapefruit, and alcohol for a few days before and during the study
- No recent blood donation (within 3 months) or participation in other drug studies
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how a new medicine, D-2570, interacts with other drugs in healthy adults. It helps find the right dose and safety before it is tested in patients.
This study checks how befotertinib, an experimental cancer drug, interacts with other drugs in healthy people. It helps make sure the drug is safe and works well when taken with other medicines.
This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.
This study tests how a medication called itraconazole affects the levels of a new drug called HS-10504 in your body. It aims to see if taking these together changes how the new drug is absorbed or processed, which helps decide safe dosing for future patients.
This trial checks if a new drug (AZD4144) works differently when taken with an antifungal medicine (itraconazole) in healthy volunteers. It helps doctors understand how to adjust doses for people who need both medicines.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.